Transport of digoxin-loaded Polymeric Nanoparticles Across BeWo cells, an In Vitro Model of Human Placental Trophoblast

References

• Thakur V Fouron JC Mertens L Jaeggi ET . Diagnosis and management of fetal heart failure. Can. J. Cardiol.29, 759–767 (2013).
   PubMed Web of Science ®Google Scholar
• Rosenberg AA Galan HL . Fetal drug therapy. Pediatr. Clin. North Am.44, 113–135 (1997).
   PubMed Web of Science ®Google Scholar
• Huhta JC . Fetal congestive heart failure. Semin. Fetal Neonatal Med.10, 542–552 (2005).
   PubMed Web of Science ®Google Scholar
• Parker LA . Hydrops Fetalis. Newborn Infant Nurs. Rev.6, e1–e8 (2006).
   Google Scholar
• Hofstaetter C Hansmann M Eik-Nes SH Huhta JC Luther SL . A cardiovascular profile score in the surveillance of fetal hydrops. J. Matern. Fetal Neonatal Med.19, 407–413 (2006).
   PubMed Web of Science ®Google Scholar
• Mongiovì M Fesslova V Fazio G Barbaro G Pipitone S . Diagnosis and prognosis of fetal cardiomyopathies: a review. Curr. Pharm. Des.16, 2929–2934 (2010).
   PubMed Web of Science ®Google Scholar
• McElhinney DB Tworetzky W Lock JE . Current status of fetal cardiac intervention. Circulation121, 1256–1263 (2010).
   PubMed Web of Science ®Google Scholar
• Petropoulos S Gibb W Matthews SG . Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation. Brain Res.1357, 9–18 (2010).
   PubMed Web of Science ®Google Scholar
• Utoguchi N Chandorkar GA Avery M Audus KL . Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod. Toxicol.14, 217–224 (2000).
   PubMed Web of Science ®Google Scholar
• Kleinman CS Nehgme RA . Cardiac arrhythmias in the human fetus. Pediatr. Cardiol.25, 234–251 (2004).
   PubMed Web of Science ®Google Scholar
• Ward RM . Pharmacology of the maternal-placental-fetal-unit and fetal therapy. Prog. Pediatr. Cardiol.5, 79–89 (1996).
   Web of Science ®Google Scholar
• Cartwright L Poulsen MS Nielsen HM et al. In vitro placental model optimization for nanoparticle transport studies. Int. J. Nanomedicine7, 497–510 (2012).
   PubMed Web of Science ®Google Scholar
• Danhier F Ansorena E Silva JM Coco R Le Breton A Préat V . PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release161, 505–522 (2012).
   PubMed Web of Science ®Google Scholar
• Campolongo MJ Luo D . Drug delivery: old polymer learns new tracts. Nat. Mater.8, 447–448 (2009).
   PubMed Web of Science ®Google Scholar
• Poulsen MS Rytting E Mose T Knudsen LE . Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol. In Vitro23, 1380–1386 (2009).
   PubMed Web of Science ®Google Scholar
• Hemauer SJ Patrikeeva SL Nanovskaya TN Hankins GD Ahmed MS . Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. Biochem. Pharmacol.78, 1272–1278 (2009).
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M Rytting E Lebhardt T Wang X Kissel T . Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the ‘ouzo region’ upon drug loading. Eur. J. Pharm. Sci.41, 244–253 (2010).
   PubMed Web of Science ®Google Scholar
• Rytting E Bur M Cartier R et al. In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles. J. Control. Release141, 101–107 (2010).
   PubMed Web of Science ®Google Scholar
• Hu L Jia H Luo Z Liu C Xing Q . Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles. Pharmazie65, 110–113 (2010).
   PubMed Web of Science ®Google Scholar
• Ali H Kalashnikova I White MA Sherman M Rytting E . Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. Int. J. Pharm.454, 149–157 (2013).
   PubMed Web of Science ®Google Scholar
• Kalashnikova I Albekairi N Al-Enazy S Rytting E . Characterization of drug-loaded nanoparticles. In : Nano Based Drug Delivery. NaikJ ( Ed.). IAPC Publishing, Zagreb, Croatia, 147–164 (2015).
   Google Scholar
• Ali H Kilic G Vincent K Motamedi M Rytting E . Nanomedicine for uterine leiomyoma therapy. Ther. Deliv.4, 161–175 (2013).
   PubMedGoogle Scholar
• Ushigome F Takanaga H Matsuo H et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur. J. Pharmacol.408, 1–10 (2000).
   PubMed Web of Science ®Google Scholar
• Nanovskaya T Nekhayeva I Karunaratne N Audus K Hankins GD Ahmed MS . Role of P-glycoprotein in transplacental transfer of methadone. Biochem. Pharmacol.69, 1869–1878 (2005).
   PubMed Web of Science ®Google Scholar
• Bode CJ Jin H Rytting E Silverstein PS Young AM Audus KL . In vitro models for studying trophoblast transcellular transport. Methods Mol. Med.122, 225–239 (2006).
   PubMedGoogle Scholar
• Huang Q Li J Wang F et al. Syncytin-1 modulates placental trophoblast cell proliferation by promoting G1/S transition. Cell. Signal.25, 1027–1035 (2013).
   PubMed Web of Science ®Google Scholar
• Liu F Soares MJ Audus KL . Permeability properties of monolayers of the human trophoblast cell line BeWo. Am. J. Physiol.273, C1596–C1604 (1997).
   PubMed Web of Science ®Google Scholar
• M⊘rck TJ Sorda G Bechi N et al. Placental transport and in vitro effects of Bisphenol A. Reprod. Toxicol.30, 131–137 (2010).
   PubMed Web of Science ®Google Scholar
• Li H van Ravenzwaay B Rietjens IM Louisse J . Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds. Arch. Toxicol.87, 1661–1669 (2013).
   PubMed Web of Science ®Google Scholar
• Huang Y Dai WG . Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta. Pharm. Sin. B4, 18–25 (2014).
   PubMed Web of Science ®Google Scholar
• Siepmann J Peppas NA . Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev.48, 139–157 (2001).
   PubMed Web of Science ®Google Scholar
• Polachek H Holcberg G Polachek J et al. Carrier-mediated uptake of Levofloxacin by BeWo cells, a human trophoblast cell line. Arch. Gynecol. Obstet.281, 833–838 (2010).
   PubMed Web of Science ®Google Scholar
• Ning YM He K Dagher R et al. Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma. Oncology (Williston Park)21, 1503–1508 (2007).
   PubMed Web of Science ®Google Scholar
• Owens DE Peppas NA . Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm.307, 93–102 (2006).
   PubMed Web of Science ®Google Scholar
• Wick P Malek A Manser P et al. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect.118, 432–436 (2010).
   PubMed Web of Science ®Google Scholar
• Rytting E Nguyen J Wang X Kissel T . Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin. Drug Deliv.5, 629–639 (2008).
   PubMed Web of Science ®Google Scholar
• Evseenko DA Paxton JW Keelan JA . ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am. J. Physiol. Regul. Integr. Comp. Physiol.290, R1357–R1365 (2006).
   PubMed Web of Science ®Google Scholar
• Lin JH Yamazaki M . Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin. Pharmacokinet.42, 59–98 (2003).
   PubMed Web of Science ®Google Scholar
• Iversen TG Skotland T Sandvig K . Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today6, 176–185 (2011).
   Web of Science ®Google Scholar